APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $527,463 | -58.8% | 13,866 | -1.3% | 0.01% | -58.8% |
| Q2 2023 | $1,279,682 | +258.3% | 14,047 | +159.4% | 0.02% | +240.0% |
| Q1 2023 | $357,173 | +28.7% | 5,415 | +0.9% | 0.01% | +25.0% |
| Q4 2022 | $277,631 | -22.7% | 5,369 | +2.2% | 0.00% | -42.9% |
| Q3 2022 | $359,000 | +62.4% | 5,255 | +7.6% | 0.01% | +75.0% |
| Q2 2022 | $221,000 | -1.8% | 4,885 | +37.4% | 0.00% | 0.0% |
| Q2 2021 | $225,000 | – | 3,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |